WHY NOW
Verified recent context
1 itemWHY THIS GROUP EXISTS
Shared filing context
13/15 members coveredModerate filing support: the strongest shared 10-Q/K outlook is operating setup (near-term outlook) across BXMT, CHRW, HII, LKQ, MKTX, MSFT, PFSI, PHIN, WHD.
credit / rates affecting interest expense
“The quarter-over-prior year quarter increase in net interest expense of $13.2 million was primarily attributable to the $1.5 billion of 2025 Senior Notes (as defined below) and the $1.0 billion of 2026 Senior Notes (as defined below), partially offset by a lower average outstanding balance and a lower average interest rate on borrowings under our credit agreement during the quarter ended March 31, 2026.”
FICO 10-Q · 2026-04-28
restructuring affecting expense
“Restructuring Charges During the fourth quarter of fiscal 2025, we incurred charges of $10.9 million in employee separation costs due to the elimination of 226 positions throughout the Company.”
FICO 10-K · 2025-11-07
demand / volume
“nded December 31, 2025, compared to the year ended December 31, 2024, primarily due to growth from AMVUTTRA revenues driven by increased patient demand, mainly in patients with ATTR-CM in the U.S., which was partially offset by a decreased number of patients on ONPATTRO, and due to growth from an increased number of patients on GIVLAARI and OXLUMO.”
ALNY 10-K · 2026-02-12
CONFIRMATION NETWORK
Outsiders and cross-asset links
0 outsiders confirmingALNY → UVXYPositive historical lead/lag · strength 0.26
ALNY → HYGInverse historical lead/lag · strength -0.14
Filing-linked outsiders test whether the move is spreading beyond the established cohort.
No high-confidence filing-linked outsiders are available for this group yet.